Reliance Chemotex Intrinsic Value
RELCHEMQ Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹75.60 | ₹60.48 - ₹90.72 | -44.6% | EPS: ₹6.30, Sector P/E: 12x |
| Book Value Method | asset | ₹171.25 | ₹154.12 - ₹188.38 | +25.5% | Book Value/Share: ₹171.25, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹272.88 | ₹245.59 - ₹300.17 | +100.0% | Revenue/Share: ₹461.25, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹272.88 | ₹245.59 - ₹300.17 | +100.0% | EBITDA: ₹44.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹127.65 | ₹102.12 - ₹153.18 | -6.4% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹40.93 | ₹36.84 - ₹45.02 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹50.42 | ₹45.38 - ₹55.46 | -63.0% | Revenue Growth: 0.1%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹155.80 | ₹140.22 - ₹171.38 | +14.2% | EPS: ₹6.30, BVPS: ₹171.25 |
Want to compare with current market value? Check RELCHEMQ share price latest .
Valuation Comparison Chart
RELCHEMQ Intrinsic Value Analysis
What is the intrinsic value of RELCHEMQ?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Reliance Chemotex (RELCHEMQ) is ₹155.80 (median value). With the current market price of ₹136.44, this represents a +14.2% variance from our estimated fair value.
The valuation range spans from ₹40.93 to ₹272.88, indicating ₹40.93 - ₹272.88.
Is RELCHEMQ undervalued or overvalued?
Based on our multi-method analysis, Reliance Chemotex (RELCHEMQ) appears to be trading below median value by approximately 14.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.91 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 3.46 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 3.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.78x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Reliance Chemotex
Additional stock information and data for RELCHEMQ
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹11 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹18 Cr | ₹-23 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹0 Cr | ₹-26 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹59 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹27 Cr | ₹6 Cr | Positive Free Cash Flow | 7/10 |